Loading…
Allarity Therapeutics, Inc. is projected to rise to $1.61 by 2027, a +26% move from its current price of $1.27. ALLR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.23 | $1.27 | $1.31 | -0.07% |
| Aug 6 | $1.21 | $1.27 | $1.33 | -0.13% |
| Aug 7 | $1.20 | $1.27 | $1.34 | -0.20% |
| Aug 8 | $1.19 | $1.27 | $1.35 | -0.26% |
| Aug 9 | $1.18 | $1.27 | $1.36 | -0.33% |
| Aug 10 | $1.17 | $1.26 | $1.37 | -0.40% |
| Aug 11 | $1.16 | $1.26 | $1.38 | -0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.16 | $1.26 | $1.38 | -0.46% |
| Week 2 | $1.11 | $1.26 | $1.42 | -0.92% |
| Week 3 | $1.08 | $1.25 | $1.46 | -1.38% |
| Week 4 | $1.05 | $1.25 | $1.48 | -1.83% |
| Week 5 | $1.02 | $1.24 | $1.51 | -2.28% |
| Week 6 | $0.999 | $1.24 | $1.53 | -2.73% |
| Week 7 | $0.9776 | $1.23 | $1.55 | -3.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Allarity Therapeutics, Inc. is a clinical-stage precision medicine pharmaceutical company focused on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. Its work centers on personalized cancer treatment using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.
Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for advanced and recurrent ovarian cancer.
The company also develops stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
ALLR is currently priced at $1.20 per share with a market cap of $19.09M, ranking 4,847 by market capitalization. The near-term forecast shows a neutral stance in 2026 with an average price of $1.20 and a 0% ROI, followed by a bullish trajectory in the years that follow as averages rise and sentiment shifts to BULLISH. The 2027 forecast implies an average of $1.69 with a 41.1% ROI, and the path continues higher toward multi-year highs in the 2030s and 2040s, reaching an average of $6.48 by 2050 and a 440.1% ROI.
A major floor 24.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 12.6% above — a clean break opens room to run.
A major ceiling 39.4% above — clearing it would confirm fresh momentum.
Key ALLR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALLR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.20 | Buy | $1.21 | Buy |
| MA 10 | $1.21 | Buy | $1.20 | Buy |
| MA 20 | $1.19 | Buy | $1.22 | Buy |
| MA 50 | $1.38 | Sell | $1.29 | Sell |
| MA 100 | $1.33 | Sell | $1.32 | Sell |
| MA 200 | $1.23 | Buy | $236.38 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.83 | Neutral |
| Stoch RSI (14) | 69.63 | Neutral |
| CCI (20) | 50.15 | Neutral |
| Williams %R (14) | -58.33 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 2.54 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 41.67 | Neutral |
| TRIX (15) | -0.59 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 44.33 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 1.19 | Buy |
| ADX (14) | 14.55 | Neutral |
| ATR (14) | 0.04 | Info |
Near term technicals are NEUTRAL with RSI14 at 40. The SMA50 sits at $1.47 and the SMA200 at $1.27, placing price action around a key support at $1.20 and beneath a resistance at $1.77. The 30-day range spans from a low of $0.9249 to a high of $1.56. Annualized volatility is high at 80%, indicating notable short-term swings around the price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.81 | $1.27 | $1.54 | 0% | Neutral | |
| $1.26 | $1.61 | $2.18 | +26% | Bullish | |
| $1.33 | $1.76 | $2.50 | +39% | Bullish | |
| $1.29 | $1.75 | $2.57 | +38% | Bullish | |
| $1.26 | $1.75 | $2.65 | +38% | Bullish | |
| $1.25 | $1.79 | $2.77 | +41% | Bullish | |
| $1.37 | $2.00 | $3.16 | +57% | Bullish | |
| $1.54 | $2.30 | $3.71 | +81% | Bullish | |
| $1.72 | $2.61 | $4.29 | +106% | Bullish | |
| $1.78 | $2.75 | $4.60 | +117% | Bullish | |
| $2.39 | $4.03 | $7.22 | +217% | Bullish | |
| $2.98 | $5.86 | $11.63 | +362% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.81 | $1.27 | $1.50 | +0.00% |
| September 2026 | $0.9949 | $1.18 | $1.45 | -6.85% |
| October 2026 | $0.9973 | $1.20 | $1.49 | +1.08% |
| November 2026 | $1.02 | $1.23 | $1.55 | +3.16% |
| December 2026 | $0.9976 | $1.21 | $1.54 | -1.76% |
Click any year to see its month-by-month ALLR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ALLR could reach as high as $1.54, with a base case around $1.27 and support toward $0.81 — roughly 0% from $1.27. Price action looks broadly range-bound.
Expect ALLR to range from $1.26 to $2.18 through 2027. The $1.61 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ALLR price prediction for 2028 points to an average of $1.76 (low $1.33, high $2.50) — a potential gain of +39% on today's $1.27. Momentum favours further upside here.
In 2029, ALLR is projected to trade between $1.29 and $2.57, averaging $1.75 — a potential gain of +38% from today's $1.27. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Allarity Therapeutics, Inc.'s 2030 outlook centres on $1.75, within a $1.26 to $2.65 range. That is up 0% on the projected 2029 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2031, ALLR could reach as high as $2.77, with a base case around $1.79 and support toward $1.25 — roughly +41% from $1.27. Buyers look set to stay in control over this stretch.
Expect ALLR to range from $1.37 to $3.16 through 2032. The $2.00 average target implies a +57% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The ALLR price prediction for 2033 points to an average of $2.30 (low $1.54, high $3.71) — a potential gain of +81% on today's $1.27. Buyers look set to stay in control over this stretch.
In 2034, ALLR is projected to trade between $1.72 and $4.29, averaging $2.61 — a potential gain of +106% from today's $1.27. That is up +14% on the projected 2033 average. Momentum favours further upside here.
Allarity Therapeutics, Inc.'s 2035 outlook centres on $2.75, within a $1.78 to $4.60 range. That is up +5% on the projected 2034 average. That marks a +117% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ALLR could reach as high as $7.22, with a base case around $4.03 and support toward $2.39 — roughly +217% from $1.27. Momentum favours further upside here.
Expect ALLR to range from $2.98 to $11.63 through 2050. The $5.86 average target implies a +362% move from current prices. That is up +46% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALLR today (≈ 787.401575 ALLR) could be worth
$4,615.18
+$3,615.18 (+362%) by 2050 · US Dollar
Based on the average projected ALLR price of $5.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALLRwould be worth at today's price.
$1,000 invested in ALLR on Jul 31, 2025 (≈ 961.538497 ALLR) would be worth
$1,221.15
+$221.15 (+22.1%) today · 1.22× · US Dollar
Based on a ALLR entry price of $1.04 vs. today's $1.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.19 | $1,067.23 | +6.7% |
| 1 month ago | $1.33 | $954.89 | -4.5% |
| 3 months ago | $1.3 | $976.92 | -2.3% |
| 6 months ago | $0.964 | $1,317.43 | +31.7% |
| 1 year ago | $1.04 | $1,221.15 | +22.1% |
| All time (4.6y) ago | $8,820,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALLR forecast.
Our base-case forecast reaches $2.50 around 2034.
Implied market cap at $2.50: $39.78M
The multi-year forecast paints a bullish trajectory after a neutral 2026, with sustained upside across the horizon. By 2027 the average price is projected at $1.69 and rises through subsequent years to an average of $1.85 in 2030, $2.56 in 2033, and $2.86 in 2035, with higher upside in the later years. The forecast shows a max path reaching $4.74 by 2034 and $5.09 by 2035, then accelerating to $8.13 in 2040 and $13.98 by 2050, with corresponding ROIs of 54.1% in 2030, 113% in 2033, 126.2% in 2034, 138.2% in 2035, 251.7% in 2040, and 440.1% in 2050.
The sentiment is consistently BULLISH from 2027 onward, reflecting an extended upside potential, though these are estimates and not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
Avg $1.85, min $1.26, max $2.93, ROI 54.1%, sentiment BULLISH.
From 2027 onward the forecast shows BULLISH sentiment with rising averages (2027 avg $1.69; 2028 $1.73; 2030 $1.85; 2040 $4.22; 2050 $6.48) and positive ROI (e.g., 41.1% in 2027, 251.7% in 2040, 440.1% in 2050). The 2026 outlook is neutral, and these figures are estimates, not guarantees.
Yes. The forecast shows max values such as 2033 $4.37, 2034 $4.74, 2035 $5.09, 2040 $8.13, and 2050 $13.98.
$0.9249 to $1.56.
Current price $1.20; market cap $19.09M; rank 4847.
Allarity Therapeutics, Inc. Community Discussion
0Share your Allarity Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.